3 Dow STARS Shining in the Late Day RALLY

Pfizer Inc. (NYSE:PFE) granted an exclusive license to VS-6063 to Verastem (VSTM), for which the latter provided updates to the product portfolio and advancements in the research and development pipeline. VS-6063, a focal adhesion kinase inhibitor that has completed a Phase 1 clinical evaluation in advanced solid tumors, was well tolerated, showed signs of clinical activity in the study, and is expected to enter into a Phase 2 mesothelioma evaluation in mid-2013. Upon completion, a positive Phase 2 in mesothelioma could yield an opportunity for an accelerated FDA approval. Clinical development is expected to begin in mid-2013 in advanced solid tumors with a high percentage of cancer stem cells.

Don’t Miss: Wall Street Brief: Yahoo Finds NEW CEO, Chevron Gets LUCKY.

Procter & Gamble Co. (NYSE:PG): Consumer products companies are employing new tech to discover what shoppers really think, by finding out what they say, according to the WSJ. They’re joining 3D computer simulations of product designs, and layouts of stores with tech that tracks eye movement, which is helping them launch new products more rapidly and create designs and shelf layouts that increase sales.

Wal-Mart Stores Inc. (NYSE:WMT) Sam’s Club is currently taking pre-orders for Google’s (NASDAQ:GOOG) Nexus 7 tablet, says the Sam’s Club’s website, which added that the device is expected to be shipped to the stores between July 17 and July 20.

Investing Insights: Fastenal Earnings CHEAT SHEET: Double-Digit Growth AGAIN!

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.